CUMBERLAND – Advanced Placement Biology students at Cumberland High School conducted a hands-on lab experiment using ...
A phase 3 trial of patients with moderate-to-severe TED has shown that subcutaneous injection of Tepezza by way of an on-body ...
A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...
Zacks Investment Research on MSN

Amgen (AMGN) laps the stock market: Here's why

In the latest close session, Amgen (AMGN) was up +1.69% at $355.30. This move outpaced the S&P 500's daily gain of 1.2%. Elsewhere, the Dow gained 1.79%, while the tech-heavy Nasdaq added 1.52%. Prior ...
Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.
Biotech company Amgen is investing $600 million into a new research center for its Thousand Oaks campus. The new site will create hundreds of jobs and feature advanced automation and digital ...
Amgen Inc. (NASDAQ:AMGN) is included among the 10 Healthcare Stocks with Highest Dividends. On April 13, UBS lifted its price ...
Biotech stocks continue to outperform in the current stock market rally, as Dow Jones index component and industry giant AmgenAMGN, along with Gilead SciencesGILD, Vertex PharmaceuticalsVRTX, ...
Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January 26, UBS lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $390 from ...
On April 13, UBS lifted its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $400 from $390. It reiterated a Buy rating on ...
LASEC and the Los Angeles World Cup 2026 Host Committee Will Collaborate with Amgen to Amplify Community Health and Legacy Programs in Greater Los Angeles Ahead of Historic Sporting Events LOS ANGELES ...
Thousand Oaks-based Amgen acquires Dark Blue Therapeutics in an $840 million deal. Thousand Oaks-based Amgen Inc. on Jan. 6 announced it has acquired Oxford, U.K.-based Dark Blue Therapeutics Ltd., a ...